Frontlight ResearchEarly access
Idiopathic pulmonary fibrosis trials in New Zealand
5 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleStudy to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
- Where
- Christchurch, Epsom, Hamilton, Papatoetoe
- Age
- 40 years and over
- People
- 324 worldwide
- Run by
- Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00 - Phase 2Taking peopleAn Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- Where
- Auckland, Christchurch, Dunedin, Hamilton, Tauranga
- Age
- 18 years and over
- People
- 340 worldwide
- Run by
- Avalyn Pharma Inc.
See details and how to joinNCT06951217 - Phase 3Enrolling by invitationExtension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
- Where
- Christchurch, Hamilton
- Age
- 40 years and over
- People
- 1,850 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT04905693 - Phase 2Taking peopleAURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
- Where
- Auckland, Christchurch, Hamilton
- Age
- 40 years and over
- People
- 160 worldwide
- Run by
- Avalyn Pharma Inc.
See details and how to joinNCT07194382 · EU 2025-523431-19-00 - Phase 3Taking peopleStudy of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Where
- Auckland, Christchurch, Hamilton
- Age
- 18 years and over
- People
- 698 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT05943535 · EU 2023-504904-26-00